Literature DB >> 1333465

Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction-single strand conformation polymorphism analysis.

M Naito1, M Satake, E Sakai, Y Hirano, N Tsuchida, H Kanzaki, Y Ito, T Mori.   

Abstract

The presence of mutations in the p53 gene was examined in ovarian cancers by a polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis. The primers were designed to amplify exons 5 through 9 that contain phylogenetically conserved domains of the p53 gene. Mutations were detected in 5 out of 10 cases, one of which contained a deletion in the second allele. A single base substitution was detected in 4 cases at codons 162, 175, 205 and 273 and a single base insertion in one case within codon 315. A high frequency of p53 mutations in ovarian cancers and lack of mutation in 6 benign ovarian tumors and 2 normal ovaries suggested that the mutation of the p53 gene was associated with the genesis and/or progression of ovarian cancer. In 1 of 7 endometrial cancers, two mutations at codons 239 and 254 were detected.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333465      PMCID: PMC5918670          DOI: 10.1111/j.1349-7006.1992.tb02717.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  44 in total

1.  Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis.

Authors:  G Shaulsky; N Goldfinger; A Ben-Ze'ev; V Rotter
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  Genetic mechanisms of tumor suppression by the human p53 gene.

Authors:  P L Chen; Y M Chen; R Bookstein; W H Lee
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

3.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

4.  MspI polymorphism of the human p53 gene.

Authors:  O de la Calle-Martín; M Romero; V Fabregat; G Ercilla; J Vives; J Yagüe
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

5.  AccII polymorphism of the p53 gene.

Authors:  O de la Calle-Martín; V Fabregat; M Romero; J Soler; J Vives; J Yagüe
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

6.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Authors:  G Gaidano; P Ballerini; J Z Gong; G Inghirami; A Neri; E W Newcomb; I T Magrath; D M Knowles; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 7.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

8.  p53 mutations in ovarian cancer: a late event?

Authors:  R Mazars; P Pujol; T Maudelonde; P Jeanteur; C Theillet
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

9.  Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53.

Authors:  T Soussi; C Caron de Fromentel; M Méchali; P May; M Kress
Journal:  Oncogene       Date:  1987-03       Impact factor: 9.867

10.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

View more
  9 in total

1.  Immunostaining of p53 protein in ovarian carcinoma: correlation with histopathological data and clinical outcome.

Authors:  A Reles; A Schmider; M F Press; I Schönborn; W Friedmann; S Huber-Schumacher; T Strohmeyer; W Lichtenegger
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.

Authors:  Teodora A Todorova; Stanislav H Jordanov; Gergana S Stancheva; Ivan J Chalakov; Mincho B Melnicharov; Kuncho V Kunev; Vanio I Mitev; Radka P Kaneva; Teodora E Goranova
Journal:  Pathol Oncol Res       Date:  2014-08-23       Impact factor: 3.201

3.  Beyond knockout rats: new insights into finer genome manipulation in rats.

Authors:  Guanyi Huang; Chang Tong; Dhruv S Kumbhani; Charles Ashton; Hexin Yan; Qi-Long Ying
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

4.  Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor.

Authors:  Angela D Bhalla; Sharon M Landers; Anand K Singh; Jace P Landry; Michelle G Yeagley; Gabryella S B Myerson; Cristian B Delgado-Baez; Stephanie Dunnand; Theresa Nguyen; Xiaoyan Ma; Svetlana Bolshakov; Brian A Menegaz; Salah-Eddine Lamhamedi-Cherradi; Xizeng Mao; Xingzhi Song; Alexander J Lazar; Ian E McCutcheon; John M Slopis; Joseph A Ludwig; Dina C Lev; Kunal Rai; Keila E Torres
Journal:  Lab Invest       Date:  2022-02-28       Impact factor: 5.662

5.  Immunohistochemical analysis of p53 protein and 72 kDa heat shock protein (HSP72) expression in ovarian carcinomas. Correlation with clinicopathology and sex steroid receptor status.

Authors:  M Koshiyama; I Konishi; M Mandai; T Komatsu; S Yamamoto; K Nanbu; T Mori
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status.

Authors:  M Koshiyama; I Konishi; D P Wang; M Mandai; T Komatsu; S Yamamoto; K Nanbu; M F Naito; T Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 7.  The genetic analysis of ovarian cancer.

Authors:  A N Shelling; I E Cooke; T S Ganesan
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

8.  Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.

Authors:  S Nakagawa; H Yoshikawa; H Jimbo; T Onda; T Yasugi; K Matsumoto; N Kino; K Kawana; T Kozuka; K Nakagawa; M Aoki; Y Taketani
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

9.  Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases.

Authors:  A Platz; P Sevigny; T Norberg; P Ring; B Lagerlöf; U Ringborg
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.